4DMedical Limited (ASX: 4DX) announced a commercial partnership with Perth Radiological Clinics to introduce its innovative XV Technology-enabled ventilation reports across 16 clinics in Perth. This strategic alliance represents a transformative leap in 4DMedical's commitment to revolutionizing healthcare in Australia. As a leading diagnostic imaging provider in Western Australia, PRC commands a significant share of the Perth market, making this collaboration a vital opportunity for 4DMedical to enhance its influence across the region. The partnership swiftly gained momentum after 4DMedical's compelling presentation at the RANZCR Annual Scientific Meeting, where PRC's chest radiologists were impressed by the substantial clinical advantages that XV Technology offers.
This collaboration not only underscores 4DMedical's dedication to innovation but also reflects its unwavering focus on improving patient outcomes in the respiratory health domain.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 20, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.